Healthline Aerosol Medicine can work with respiratory
therapy department directors to help them develop a
Financial Impact Assessment to justify the purchase of our
product. The Impact Assessment Tool is available at no
cost; the only requirement is that the director must be able
to download and open a Microsoft Excel spreadsheet.
Contact us by
e-mail to
request your Free Impact Assessment and see how much you
could save by using The Medicator®.
The Impact Assessment is based upon the premise that use of
the Medicator, while more expensive to purchase than a
conventional "tee" style SVN, is actually more
economical to use over the course of a patient's
hospitalization. Another way of stating the premise
is:
|
It's
not how much the aerosol delivery device costs
that's important;
it's the Total Cost of Therapy by the time
the patient is discharged. |
To demonstrate, here is a
"Total Cost of Therapy" graph taken from a typical Financial Impact Assessment:
The variables
used in this particular analysis are:
Conventional
SVN Therapy
Labor cost: $20.20/hour
Initial Tx duration: 20 mins
Subsequent Tx duration: 15 mins
Drug cost: $0.89
Supply cost (nebulizer): $0.79 |
Therapy
with The Medicator
Labor cost: $20.20/hour
Initial Tx duration: 10 mins
Subsequent Tx duration: 7.5 mins
Drug cost: $0.89
Supply cost (Medicator): $5.75 |
Analysis:
Labor cost ($20.20/hour) was the same in each scenario.
Therapy with the Medicator was evaluated using a treatment
duration that was exactly one half of that of the conventional
therapy. The drug cost (unit dose albuterol) was the
same in each scenario. The supply cost varied from $0.79
for a simple "tee" nebulizer for conventional
therapy to $5.75 for The Medicator. Analysis was carried
out for an arbitrary total of 21 treatments (representing the
number of treatments the patient received at time of hospital
discharge).
Results:
Despite the fact
that the first treatment had a supply cost of only 79¢ for
the conventional nebulizer versus $5.75 for The
Medicator, the Total Cost of Therapy when the patient
was discharged was $127.21 for conventional therapy and only
$78.31 for therapy with The Medicator. The savings was
$48.91.
Don't
underestimate the impact of labor costs. A close look at
the graph will show that the two cost trend lines crossed at
the second treatment.
| The
reason for the savings was reduction of labor!
Labor is the most expensive aspect of most hospital
procedures, including aerosol drug therapy. The
cost of the aerosol delivery device is unimportant IF
it reduces the labor cost AND provides optimal
therapy. The Medicator does both. |
Company
| Contacts
| Products
| Sales
|
